Credit Acceptance (NASDAQ:CACC) Releases Earnings Results, Beats Estimates By $0.15 EPS

Gilead Sciences, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:GILD) 2026-10-29

2026-10-29. The following slide deck was published by Gilead Sciences, Inc.

Gilead hikes full-year sales outlook, quarterly HIV sales rise 18% - Regional Media News

By Deena Beasley Oct 29 (Reuters) - Gilead Sciences hiked its full-year sales outlook on Thursday and reported third-quarter product sales rose 13%, driven by a double-digit percentage jump for its flagship HIV drug franchise. The company reported quarterly adjusted earnings of $2.55 per share [...]

Credit Acceptance (NASDAQ:CACC) Releases Earnings Results, Beats Estimates By $0.15 EPS

Credit Acceptance (NASDAQ:CACC - Get Free Report) posted its quarterly earnings data on Thursday. The credit services provider reported $13.01 EPS for the quarter, beating analysts' consensus estimates of $12.86 by $0.15. Credit Acceptance had a net margin of 21.54% and a return on equity of 31.67%. The business had revenue of $420.30 million for the quarter, compared to analyst estimates of $596.40 million.

Gilead hikes full-year sales outlook, quarterly HIV sales rise 18%

By Deena Beasley Oct 29 (Reuters) - Gilead Sciences hiked its full-year sales outlook on Thursday and reported third-quarter product sales rose 13%, driven by a ​double-digit percentage jump for its flagship HIV drug ‌franchise. The company reported qu...

Gilead Hits A Record High, Notches Best Growth In A Decade

Gilead Sciences crushed Wall Street's sales expectations on the back of its HIV treatments and cancer drug Trodelvy.

Gaming and Leisure Properties: Q3 Earnings Snapshot

WYOMISSING, Pa. (AP) — WYOMISSING, Pa. (AP) — Gaming and Leisure Properties Inc. (GLPI) on Thursday reported a key measure of profitability in its third quarter. The results beat Wall Street expectations.